Search Results - "Oyen, Wim"

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 by Boellaard, Ronald, Delgado-Bolton, Roberto, Oyen, Wim J. G., Giammarile, Francesco, Tatsch, Klaus, Eschner, Wolfgang, Verzijlbergen, Fred J., Barrington, Sally F., Pike, Lucy C., Weber, Wolfgang A., Stroobants, Sigrid, Delbeke, Dominique, Donohoe, Kevin J., Holbrook, Scott, Graham, Michael M., Testanera, Giorgio, Hoekstra, Otto S., Zijlstra, Josee, Visser, Eric, Hoekstra, Corneline J., Pruim, Jan, Willemsen, Antoon, Arends, Bertjan, Kotzerke, Jörg, Bockisch, Andreas, Beyer, Thomas, Chiti, Arturo, Krause, Bernd J.

“…The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological…”
Get full text

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms by Ambrosini, Valentina, Kunikowska, Jolanta, Baudin, Eric, Bodei, Lisa, Bouvier, Catherine, Capdevila, Jaume, Cremonesi, Marta, de Herder, Wouter W., Dromain, Clarisse, Falconi, Massimo, Fani, Melpomeni, Fanti, Stefano, Hicks, Rodney J., Kabasakal, Levent, Kaltsas, Gregory, Lewington, Val, Minozzi, Silvia, Cinquini, Michela, Öberg, Kjell, Oyen, Wim. J.G., O'Toole, Dermot, Pavel, Marianne, Ruszniewski, Philippe, Scarpa, Aldo, Strosberg, Jonathan, Sundin, Anders, Taïeb, David, Virgolini, Irene, Wild, Damian, Herrmann, Ken, Yao, James

“…Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission…”
Get full text

The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer by Giammarile, Francesco, Alazraki, Naomi, Aarsvold, John N., Audisio, Riccardo A., Glass, Edwin, Grant, Sandra F., Kunikowska, Jolanta, Leidenius, Marjut, Moncayo, Valeria M., Uren, Roger F., Oyen, Wim J. G., Valdés Olmos, Renato A., Vidal Sicart, Sergi

“…Purpose The accurate harvesting of a sentinel node in breast cancer includes a sequence of procedures with components from different medical specialities,…”
Get full text

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 by Boellaard, Ronald, O’Doherty, Mike J., Weber, Wolfgang A., Mottaghy, Felix M., Lonsdale, Markus N., Stroobants, Sigrid G., Oyen, Wim J. G., Kotzerke, Joerg, Hoekstra, Otto S., Pruim, Jan, Marsden, Paul K., Tatsch, Klaus, Hoekstra, Corneline J., Visser, Eric P., Arends, Bertjan, Verzijlbergen, Fred J., Zijlstra, Josee M., Comans, Emile F. I., Lammertsma, Adriaan A., Paans, Anne M., Willemsen, Antoon T., Beyer, Thomas, Bockisch, Andreas, Schaefer-Prokop, Cornelia, Delbeke, Dominique, Baum, Richard P., Chiti, Arturo, Krause, Bernd J.

“…The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG)…”
Get full text

Medical imaging and nuclear medicine: a Lancet Oncology Commission by Hricak, Hedvig, Abdel-Wahab, May, Atun, Rifat, Lette, Miriam Mikhail, Paez, Diana, Brink, James A, Donoso-Bach, Lluís, Frija, Guy, Hierath, Monika, Holmberg, Ola, Khong, Pek-Lan, Lewis, Jason S, McGinty, Geraldine, Oyen, Wim J G, Shulman, Lawrence N, Ward, Zachary J, Scott, Andrew M

“…The diagnosis and treatment of patients with cancer requires access to imaging to ensure accurate management decisions and optimal outcomes. Our global…”
Get full text

Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy by Stillebroer, Alexander B, Mulders, Peter F.A, Boerman, Otto C, Oyen, Wim J.G, Oosterwijk, Egbert

“…Abstract Context The clinical management of patients with renal cell carcinoma (RCC) remains difficult, and the development of new diagnostic, prognostic, and…”
Get full text

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer by Fanti, Stefano, Goffin, Karolien, Hadaschik, Boris A, Herrmann, Ken, Maurer, Tobias, MacLennan, Steven, Oprea-Lager, Daniela E., Oyen, Wim JG, Rouvière, Olivier, Mottet, Nicolas, Bjartell, Anders

“…Purpose Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and…”
Get full text

Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies by Heskamp, Sandra, Hobo, Willemijn, Molkenboer-Kuenen, Janneke D M, Olive, Daniel, Oyen, Wim J G, Dolstra, Harry, Boerman, Otto C

“…Antibodies that block the interaction between programmed death ligand 1 (PD-L1) and PD-1 have shown impressive antitumor activity. Patients with tumors…”
Get full text

Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor by Helmich, Rick C., Janssen, Marcel J. R., Oyen, Wim J. G., Bloem, Bastiaan R., Toni, Ivan

“…Objective: Parkinson disease (PD) is characterized by striatal dopamine depletion, which explains clinical symptoms such as bradykinesia and rigidity, but not…”
Get full text

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients by TEL, Jurjen, AARNTZEN, Erik H. J. G, WINKELS, Gregor, COULIE, Pierre G, PUNT, Cornelis J. A, FIGDOR, Carl G, DE VRIES, I. Jolanda M, BABA, Tetsuro, SCHREIBELT, Gerty, SCHULTE, Barbara M, BENITEZ-RIBAS, Daniel, BOERMAN, Otto C, CROOCKEWIT, Sandra, OYEN, Wim J. G, VAN ROSSUM, Michelle

“…Vaccination against cancer by using dendritic cells has for more than a decade been based on dendritic cells generated ex vivo from monocytes or CD34(+)…”
Get full text

Managing Nonmetastatic Castration-resistant Prostate Cancer by Mateo, Joaquin, Fizazi, Karim, Gillessen, Silke, Heidenreich, Axel, Perez-Lopez, Raquel, Oyen, Wim J.G., Shore, Neal, Smith, Matthew, Sweeney, Christopher, Tombal, Bertrand, Tomlins, Scott A., de Bono, Johann S.

“…Patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) have rising prostate-specific antigen (PSA) and castrate testosterone levels, with no…”
Get full text

Zirconium-89 Labeled Antibodies : A New Tool for Molecular Imaging in Cancer Patients by Perk, Lars, van de Watering, Floor C. J., Boerman, Otto C., Oyen, Wim J. G., Brinkmann, Ulrich, Rijpkema, Mark

“…Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visualize and characterize tumor lesions. Additionally, it can…”
Get full text

Fever of Unknown Origin: the Value of FDG-PET/CT by Kouijzer, Ilse J.E., Mulders-Manders, Catharina M., Bleeker-Rovers, Chantal P., Oyen, Wim J.G.

“…Fever of unknown origin (FUO) is commonly defined as fever higher than 38.3°C on several occasions during at least 3 weeks with uncertain diagnosis after a…”
Get full text

The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe by Patt, Marianne, Decristoforo, Clemens, de Martini, Amélie, Koole, Michel, Oyen, Wim J. G., Kiss, Oliver C.

Get full text

Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models by Burley, Thomas A, Da Pieve, Chiara, Martins, Carlos D, Ciobota, Daniela M, Allott, Louis, Oyen, Wim J G, Harrington, Kevin J, Smith, Graham, Kramer-Marek, Gabriela

“…In head and neck squamous cell cancer, the human epidermal growth factor receptor 1 (EGFR) is the dominant signaling molecule among all members of the family…”
Get full text

The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials by Boellaard, Ronald, Oyen, Wim J. G., Hoekstra, Corneline J., Hoekstra, Otto S., Visser, Eric P., Willemsen, Antoon T., Arends, Bertjan, Verzijlbergen, Fred J., Zijlstra, Josee, Paans, Anne M., Comans, Emile F. I., Pruim, Jan

“…Introduction Several studies have shown the usefulness of positron emission tomography (PET) quantification using standardised uptake values (SUV) for…”
Get full text

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial by Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, Wim. J.G., Keijsers, R. G.

“…Introduction Immune-mediated interstitial pneumonitis may be treated with anti-CD20 therapy after failure of conventional therapies. However, clinical response…”
Get full text

Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice? by Vriens, Dennis, de Koster, Elizabeth J., de Geus-Oei, Lioe-Fee, Oyen, Wim J. G.

Get full text

Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules by de Koster, Elizabeth J, de Geus-Oei, Lioe-Fee, Dekkers, Olaf M, van Engen-van Grunsven, Ilse, Hamming, Jaap, Corssmit, Eleonora P M, Morreau, Hans, Schepers, Abbey, Smit, Jan, Oyen, Wim J G, Vriens, Dennis

“…Indeterminate thyroid cytology (Bethesda III and IV) corresponds to follicular-patterned benign and malignant lesions, which are particularly difficult to…”
Get full text

PET in the management of locally advanced and metastatic NSCLC by Grootjans, Willem, de Geus-Oei, Lioe-Fee, Troost, Esther G. C., Visser, Eric P., Oyen, Wim J. G., Bussink, Johan

“…Key Points Disease-specific survival of patients with advanced-stage non-small-cell lung cancer remains poor; combined and intensified treatments have failed…”
Get full text